cl 232468 has been researched along with mitoxantrone in 7 studies
*Mitoxantrone: An anthracenedione-derived antineoplastic agent. [MeSH]
*Mitoxantrone: An anthracenedione-derived antineoplastic agent. [MeSH]
| Studies (cl 232468) | Trials (cl 232468) | Recent Studies (post-2010) (cl 232468) | Studies (mitoxantrone) | Trials (mitoxantrone) | Recent Studies (post-2010) (mitoxantrone) |
|---|---|---|---|---|---|
| 8 | 0 | 2 | 4,555 | 1,042 | 1,004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Collins, JG; Cutts, SM; Evison, BJ; Kelso, C; Konda, SK; Medan, J; Phillips, DR; Pumuye, PP; Sleebs, BE; Watson, K | 1 |
| Cornacoff, JB; Dean, JH; House, RV; Pallardy, MJ; Thurmond, LM | 1 |
| Dean, JH; House, RV | 2 |
| Cornacoff, JB; Dean, JH; House, RV; Lauer, LD; Thurmond, LM | 1 |
| Gherson, J; Levine, S | 1 |
| Durr, FE; Lumanglas, AL; Ruszala-Mallon, VM; Wallace, RE; Wang, BS | 1 |
7 other study(ies) available for cl 232468 and mitoxantrone
| Article | Year |
|---|---|
Formaldehyde-activated WEHI-150 induces DNA interstrand crosslinks with unique structural features.
Topics: Animals; Cattle; DNA; Dose-Response Relationship, Drug; Formaldehyde; Mass Spectrometry; Mitoxantrone; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2020 |
Suppression of cytolytic function in murine lymphocytes exposed to 1,4-bis[(2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (AEAD): inhibition of proliferation by cytotoxic T-lymphocyte precursors.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Immunologic; Female; Interleukin-5; Interleukins; Kinetics; Lymphocyte Activation; Mice; Mitoxantrone; RNA; Spleen; T-Lymphocytes, Cytotoxic | 1989 |
Target cell specificity of immunosuppression in murine lymphocytes exposed to 1,4-bis[(2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (AEAD).
Topics: Animals; Antigens, Surface; Cytotoxicity, Immunologic; Female; Immunosuppression Therapy; Injections, Intraperitoneal; Interleukin-1; Interleukin-2; Mice; Mitoxantrone; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer | 1989 |
Selective immunosuppression following exposure to a novel anthraquinone, 1,4-bis[(2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (AEAD).
Topics: Animals; Antibody Formation; Female; Immunosuppression Therapy; In Vitro Techniques; Injections, Intraperitoneal; Killer Cells, Natural; Mice; Mitoxantrone; Organ Size; T-Lymphocytes, Cytotoxic; Time Factors; Viral Plaque Assay | 1989 |
Trypanosoma musculi: characterization of the T-lymphocyte dependency of immunity by selective immunomodulation of the mouse, Mus musculus.
Topics: Animals; Antibodies; Antibodies, Monoclonal; Cyclosporins; Female; Immunosuppressive Agents; Killer Cells, Natural; Kinetics; Mice; Mitoxantrone; T-Lymphocytes; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer; Trypanosomiasis | 1988 |
Morphologic effects of mitoxantrone and a related anthracenedione on lymphoid tissues.
Topics: Animals; Female; Lymph Nodes; Lymphocytes; Lymphoid Tissue; Macrophages; Male; Mice; Mitoxantrone; Rats; Rats, Inbred Lew; Spleen | 1986 |
Induction of alloreactive immunosuppression by 1,4-bis [( 2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (CL 232,468).
Topics: Animals; Anthraquinones; Bone and Bones; Cell Division; Cyclosporins; Immunity, Cellular; Immunosuppressive Agents; Isoantigens; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mitoxantrone; Spleen; T-Lymphocytes, Cytotoxic; Time Factors | 1984 |